Statin Wars: Misled by the evidence - Dr. Maryanne Demasi PhD

Maryanne Demasi BMJ paper:
https://t.co/chdqynkETW

Article:
https://pubmed.ncbi.nlm.nih.gov/25655639/

Article:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366000/

This is one of the best lectures on how criminally bad statin science is, and how the same criminal authorities and pharmaceutical companies have gone to great lengths to cover up their harmful side effects and true safety profile in effort to protect from liability and ensure maximal profit with no regard for those harmed.

Most people are unaware of this, but they have never released the raw data on statin side effects from the various studies for independent analysis. Just like the vaccine safety database, a small group of scientists and administrators keep the statin data locked up in a vault away from prying eyes or critique, in effort to protect their masters in pharmaceutical companies.

It's controlled by 1 group of researchers and led by Professor Rory Collins, which is under the CTT collaboration , which is under the CTSU Oxford.

They will occasionally publish meta-analysis using this data to advocate for increased used of statins and will claim it's independent of pharmaceutical companies, but they've also received hundreds of millions of dollars from the same pharmaceutical companies for said research, so they're obviously not impartial... Considering the lengths they go to hide this data and conflicts of interest, we should all know what's happening here and what they're hiding.
Here are some excerpts from Dr Demasi's paper published to the BMJ on this subject.

If the data are hidden, can we even have a debate?

"Much has been made about the fact that the raw data from statin trials are only available to a single group of researchers— the CTT Collaboration—and they have agreed to keep the data in confidence and will not share anonymized data with independent researchers. This is one of the most contemptible breaches in transparency. Neither the doctors prescribing statins nor the millions of people taking these medications have had access to independent analysis of the efficacy data. In addition, the side effect data were simply not collected in the vast majority of trials.

When asked in 2013, the CTT confirmed that it would not allow other scientists to access the raw statin data to conduct an independent analysis. They wrote:

->The CTT secretariat has agreement with the principal investigators of the trials and, in those instances where trial data were provided directly by the drug manufacturers, with the companies themselves, that individual trial data will not be released to third parties. Such an agreement was necessary in order that analyses of the totality of the available trial data could be conducted by the CTT Collaboration: without such an agreement the trial data could not have been brought together for systematic analysis.
Alarmingly, the widely influential analyses of the CTT Collaboration cannot be verified by independent researchers because most, if not all, of the principal investigators of the individual studies have not agreed to make their data available. Hence, the rest of us are supposed to have faith in the interpretation of the science by this select group of scientists without seeing it for ourselves.

Not even the Cochrane Collaboration had access to the patient-level data when conducting its review of statins in low-risk people, and its conclusions ultimately influenced the prescribing guidelines.

Dr Fiona Godlee, Editor in Chief of the BMJ, has called for the release of the raw data into the side effects of statins and has described the discourse as ‘a bitter and increasingly unproductive dispute’ because the data for harms have not yet been given the same level of scrutiny as the data for benefits. As in the case of the hidden data on Tamiflu, independent scrutiny of individual patient data uncovered new and revealing facts about the benefits and harms of the medications.